Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Novo Nordisk announced FDA acceptance of their New Drug Application (NDA) for a 25 mg oral version of Wegovy for two new indications: (1) chronic weight management in adults living with obesity or who are overweight with at least one comorbid condition, and (2) to reduce the risk of major adverse cardiac events (MACE) in adults with overweight or obesity and established CVD
Pettus J, Reeds D, Cavaiola TS et al (2018) Effect of a glucagon receptor antibody (REMD-477) in type 1 diabetes: A randomized controlled trial
A University of Arkansas study found giving sedentary seniors regular doses of whey doubles fat burn and can provide workout-like benefits to those with limited mobility
Previously identified FBF partners include NOS-3, a Nanos homolog which is expressed throughout the germline [67, 68], and CPEB/CPB-1, which is expressed and functions in spermatocytes [64, 69]
Relative efficacy of adalimumab versus secukinumab in active psoriatic arthritis: a matching-adjusted indirect comparison
